Funding for this research was provided by:
National Institute of Environmental Health Sciences (R01 ES030691, R00 ES024144, R21 ES029681, R01 ES016813, R01ES029944, P30 ES007048, K99 ES030400, R01 ES030364, R21 ES028903)
Horizon 2020 Framework Programme
National Cancer Institute (P01 CA196569, R01 CA140561)
Sixth Framework Programme (EU FP6. STREP Hiwate, EU FP6-2003-Food-3-NewGeneris)
Seventh Framework Programme (EU FP7-HEALTH-2009- single stage CHICOS, EU- FP7- HEALTH-2012 Proposal No 308333 HELIX, EU FP7 ENV.2008.1.2.1.6. Proposal No 226285 ENRIECO, EU FP7-2008-ENV-18.104.22.168 Envirogenomarkers, EU FP7 ENV.2007.1.2.2.2. Project No 211250 Escape)
Greek Ministry of Health
Received: 7 August 2020
Accepted: 7 December 2020
First Online: 6 January 2021
Ethics approval and consent to participate
: This study was conducted according to the principles of the Declaration of Helsinki and was approved by the ethical committee of the University Hospital in Heraklion, Greece and the Regional Ethical Review Board in Stockholm, Sweden.
: Informed consent was obtained from all study participants.
: The authors declare that they have no competing interests.